Jeffrey Dayno
2021
In 2021, Jeffrey Dayno earned a total compensation of $702.7K as EVP and Chief Medical Officer at Harmony Biosciences Holdings, a 74% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $245,093 |
|---|---|
| Salary | $445,624 |
| Other | $12,027 |
| Total | $702,744 |
Dayno received $445.6K in salary, accounting for 63% of the total pay in 2021.
Dayno also received $245.1K in non-equity incentive plan and $12K in other compensation.
Rankings
In 2021, Jeffrey Dayno's compensation ranked 9,877th out of 12,415 executives tracked by ExecPay. In other words, Dayno earned more than 20.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,877 out of 12,415 | 20th |
Division Manufacturing | 4,371 out of 5,505 | 21st |
Major group Chemicals And Allied Products | 1,946 out of 2,375 | 18th |
Industry group Drugs | 1,728 out of 2,096 | 18th |
Industry Pharmaceutical Preparations | 1,288 out of 1,546 | 17th |
Source: SEC filing on April 8, 2022.
Dayno's colleagues
We found five more compensation records of executives who worked with Jeffrey Dayno at Harmony Biosciences Holdings in 2021.
2021
Sandip Kapadia
Harmony Biosciences Holdings
Chief Financial Officer
2021
Jeffrey Dierks
Harmony Biosciences Holdings
EVP and Chief Commercial Officer
2021
John Jacobs
Harmony Biosciences Holdings
Chief Executive Officer
2021
Andrew Serafin
Harmony Biosciences Holdings
EVP and Chief Strategy Officer
2021
Susan Drexler
Harmony Biosciences Holdings